🔴 Pyxis Oncology is trading 8.3% down in after-hours trading as catalyst remains unclear

Pyxis Oncology is trading at $2.66, down 8.27%, after hours; the reason for the decline remains unclear.

• No clearly identified company-specific announcement or catalyst was dated September 29.
• The latest major update was positive Phase 1 MICVO data released September 9, which does not clearly explain this session’s move. Provided market context shows only modest index moves and does not establish a broader-market cause.